Obefazimod for colitis, ulcerative

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Dec 2021: Trial started, NCT05177835
  2. 5 Jan 2022: Trial registered, NCT05177835

The trials

NCT05177835: Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

State
Under way
Phase
Phase 2
People
203 planned
Started
3 Dec 2021
Primary completion
Mar 2028
Arms
ABX464 -25mg
Results
None posted
  1. 3 Dec 2021: Trial started
  2. 5 Jan 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.